JPS5025794A - - Google Patents

Info

Publication number
JPS5025794A
JPS5025794A JP48081939A JP8193973A JPS5025794A JP S5025794 A JPS5025794 A JP S5025794A JP 48081939 A JP48081939 A JP 48081939A JP 8193973 A JP8193973 A JP 8193973A JP S5025794 A JPS5025794 A JP S5025794A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48081939A
Other languages
Japanese (ja)
Other versions
JPS5621395B2 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP8193973A priority Critical patent/JPS5621395B2/ja
Priority to HUTA1314A priority patent/HU169795B/hu
Priority to DK386174A priority patent/DK386174A/da
Priority to SE7409334A priority patent/SE414508B/xx
Priority to BE6044693A priority patent/BE817780A/fr
Priority to NL7409768A priority patent/NL7409768A/xx
Publication of JPS5025794A publication Critical patent/JPS5025794A/ja
Publication of JPS5621395B2 publication Critical patent/JPS5621395B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
JP8193973A 1973-07-18 1973-07-18 Expired JPS5621395B2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP8193973A JPS5621395B2 (fr) 1973-07-18 1973-07-18
HUTA1314A HU169795B (fr) 1973-07-18 1974-07-17
DK386174A DK386174A (fr) 1973-07-18 1974-07-17
SE7409334A SE414508B (sv) 1973-07-18 1974-07-17 Sett att framstella cefalexinmonohydrat i form av prismatiska kristaller
BE6044693A BE817780A (fr) 1973-07-18 1974-07-17 Procede de cristallisation de cephalexine et produits obtenus (inv. : k. nara
NL7409768A NL7409768A (en) 1973-07-18 1974-07-18 Prismatic cephalexin monohydrate prodn. - from acylation broths by concentrating recovering dihydrate and drying

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8193973A JPS5621395B2 (fr) 1973-07-18 1973-07-18

Publications (2)

Publication Number Publication Date
JPS5025794A true JPS5025794A (fr) 1975-03-18
JPS5621395B2 JPS5621395B2 (fr) 1981-05-19

Family

ID=13760445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8193973A Expired JPS5621395B2 (fr) 1973-07-18 1973-07-18

Country Status (6)

Country Link
JP (1) JPS5621395B2 (fr)
BE (1) BE817780A (fr)
DK (1) DK386174A (fr)
HU (1) HU169795B (fr)
NL (1) NL7409768A (fr)
SE (1) SE414508B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4893280A (fr) * 1972-03-10 1973-12-03

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
JPS49126811A (fr) * 1973-04-10 1974-12-04

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
JPS49126811A (fr) * 1973-04-10 1974-12-04

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4893280A (fr) * 1972-03-10 1973-12-03

Also Published As

Publication number Publication date
SE7409334L (fr) 1975-01-20
JPS5621395B2 (fr) 1981-05-19
SE414508B (sv) 1980-08-04
HU169795B (fr) 1977-02-28
BE817780A (fr) 1975-01-17
NL7409768A (en) 1975-01-21
DK386174A (fr) 1975-03-24

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AR199451A1 (fr)
AR201432A1 (fr)
AR210729A1 (fr)
AR200256A1 (fr)
AR197627A1 (fr)
AR196382A1 (fr)
AR193950A1 (fr)
AU447540B2 (fr)
AR195311A1 (fr)
AU461342B2 (fr)
AR195948A1 (fr)
AR200885A1 (fr)
AU1891376A (fr)
AR196123Q (fr)